Search This Document
Search All Documents
Info | ||
---|---|---|
| ||
This section includes a short paragraph which focuses on giving a general idea about the project and key prerequisites. It provides a simple and short statement of the project and clarifies why it is needed. It explains the problems that motivated the project and outlines the expected outcomes following successful implementation Please note that this section does not provide any details about the objective, resources, methods, or other detailed information. |
Info | ||
---|---|---|
| ||
This section presents the objective of this guide. In a short and accurate manner, it presents the expectations to be satisfied when complying to the methods or artefacts presented in the guide. |
Info | ||
---|---|---|
| ||
This section describes the scope of the document and the associated work. It should clearly describe the project constraints and limitation. It should include information about what is included in the guide, but also clarify what is outside the scope of this work. |
...
title | Template Notes |
---|
...
Pathology reports specific to cancer diagnosis and prognosis are increasingly done in structured, specifically synoptic, form. These synoptic reports adhere to established guidelines and protocols set by national and international societies of pathology, national cancer registries and other similar bodies of authority. These organizations include the College of American Pathologists, the Royal College of Pathology, the Royal College of Pathology Australasia, PALGA, the International Collaboration for Cancer Reporting and others. The reporting protocols, also referred to as data sets, are highly concordant between each protocol publishing entity. There is a need to represent the data elements contained within a cancer synoptic report in both a humanly readable format as well as in a computable, machine readable form. Computable data elements can be stored within an electronic health record to support clinical care, electronically send to cancer registries for public health use, and are more readily used for clinical translational use. Prior to 2020, the SNOMED CT content available for use in cancer synoptic reporting was either not available or ambiguous in nature. In fact, the US Centers for Disease Control and Prevention (CDC) studied the use of SNOMED CT for use in cancer registry reporting in 2005 and again in 2009. The findings of these CDC studies indicated that neither SNOMED CT nor LOINC had concepts with sufficient definition to render cancer data unambiguously encoded and fit for use for cancer reporting or cancer data representation. With the increased use and requirement for structured pathology reporting and the noted deficiency in SNOMED CT content, the Cancer Synoptic Reporting Working Group (CSRWG) was formed in 2020 with the explicit objective to create the SNOMED CT concepts necessary and sufficient for use in structured pathology reports and support the clinical, public health and research uses of these data. More specifically, the objective of the CSRWG was to create the necessary SNOMED CT content for use in structured reporting for all solid tumor protocols, including pediatric protocols, published by the aforementioned bodies.
The objective of this implementation guide is to provide instruction and guidance regarding the SNOMED CT content produced by the CSRWG. The guide provides instruction on implementing SNOMED CT for use in cancer synoptic reporting. After review of this guide, the reader will have knowledge to implement SNOMED CT encoded cancer synoptic reports for use in the electronic health record, for electronic transmission and for use in analytics.
The scope of the Cancer Synoptic Reporting Working Group (CSRWG) was specific to the creation of SNOMED CT necessary to unambiguously represent the data elements required for cancer reporting for all solid tumors, adult and pediatric, as published by the College of American Pathologists (CAP) and the International Collaboration on Cancer Reporting (ICCR). The ICCR is supported by the CAP, RCPath, and RCPA as well as other societies of pathology. As a result, data sets produced by the Royal College of Pathology (RCPath) and the Royal College of Pathology Australasia (RCPA) were also used as references for this work. Data sets produced by the ICCR are open source and are now the foundation for the data sets used throughout SNOMED International Member Nations in Europe and Australasia. The protocols produced by the CAP are used in the United States and Canada and are required for laboratory certification. It is estimated that there is a 95% overlap of content between the CAP and ICCR, thus making these two protocol providers reasonable foundations for this project.
As noted the content addressed in this guide is specific to structure pathology reporting of malignant neoplasms as specified by the CAP and ICCR. The content created is intended to represent the specific observations made and reported by the pathologist during the examination of excised tissue. It is NOT intended to define the clinical interpretation of the data. Indeed, it is expected that the pathologist and clinicians using the pathology report understand the clinical meaning of the data as contained within any particular report. For example, the criteria to differentiate between an adenocarcinoma and a mucinous carcinoma in the colon versus the breast is expected to be understood by the data creator (pathologist) and user (surgeon or clinician). It is not reflected in the SNOMED CT concept.
The CSRWG highly leveraged the work of the Observables Project Group and used the observable entity hierarchy for much of the new SNOMED CT content developed in this project. This decision was made for three specific reasons:
Content included in this project consists of:
Content to be further developed:
Content NOT included in this project:
SNOMED CT is a comprehensive, multilingual clinical terminology that can be used to standardize and improve the quality of data related to <scope of document>. This guide is targeted at the various stakeholders involved with the implementation of SNOMED CT:
SNOMED International Members who are seeking uniform, clear best practices for documenting <scope of document> structured cancer pathology reports, and understanding how SNOMED CT can be applied in this domain
Clinicians who are interested in understanding how SNOMED CT can support the clinical needs for data collection and acquisition within the field of <scope of document>of cancer pathology reports for patient care.
Information managers who are looking to learn how SNOMED CT can be integrated into health information models within the domain of <scope of document> cancer pathology and cancer care to support the implementation of SNOMED CT and enhance data interoperability.
Software developers who want to learn how to integrate SNOMED CT into software applications used in the domain of <scope of document>.
...
title | Template Notes |
---|
This section presents the main contributors to this guide, e.g. a Clinical Reference Group. Update the text below as required.
It also provides information about who to contact for questions about the work presented in the guide. The information may include:
Name: [Name of individual or group]
Title: [Title of individual or group, if applicable]
Affiliation: [Affiliation of individual or group, if applicable]
Description: [Brief description of the individual or group's role or contribution to the information being attributed]
Sources: [List of sources or references used to gather information about the individual or group, if applicable]
structured cancer pathology reporting.
...
This SNOMED CT Implementation guide and the underlying work have been developed by the <name of CRG> Cancer Synoptic Reporting Working Group. The Clinical Reference Group (CRG) is composed of experts in the field of <scope of document> providing pathology providing input from the community of practice on the development, maintenance, and use of SNOMED CT in this specific domain. The CRG members have been instrumental in the development of this guide, providing their expertise, knowledge, and experience to ensure that it is accurate, up-to-date, and relevant to the needs of its intended audience. Their dedication and hard work have made this guide possible and SNOMED Internationalis is grateful for their contributions. This guide is a product of SNOMED International's ongoing commitment to improving healthcare through the use of high-quality, standardized clinical terminologies.
Panel | ||||
---|---|---|---|---|
| ||||
Add additional attributions: |
...
title | Template Notes |
---|
...
| |||
|
This SNOMED CT Implementation Guide is designed to provide guidance for the use of SNOMED CT within the domain of allergies, hypersensitivity, and intolerance. The guide is organized into five main chapters:
In addition, a number of appendixes present the results of the analysis performed and provide insights into the evolution of SNOMED CT and available information models.
...
title | Template Notes |
---|
This section provides information about the status of the work presented in this guide.
...